Abstract:The first definitive indication of a potential molecular-genetic and mechanistic link between the pathobiology of the human gastrointestinal (GI)-tract microbiome and its contribution to the pathogenetic mechanisms of sporadic Alzheimer's disease (AD) came a scant 6 years ago (Bhattacharjee S, Lukiw WJ. Alzheimer's disease and the microbiome. Front Cell Neurosci (2013) 7:153.10.3389/fncel.2013.00153). Ongoing research continues to strengthen the hypothesis that neurotoxic microbial-derived components of the GI tract microbiome (both viral- and bacterial-derived) can cross aging GI tract and blood–brain barriers and contribute to progressive pro-inflammatory neurodegeneration, as exemplified by the AD-process. Analysis, culture and extraction of Bacteroides fragilis, Escherichia coli and other Gram-negative anaerobes; bioinformatic algorithms; collection and culture of human GI tract microbial species; DNA and RNA sequencing; LED-Northern dot blotting; messenger RNA (mRNA) and micro RNA (miRNA) based microfluidic array analysis; quantitative and analytical RT-PCR and imunocytochemistry; viral assay and quantitation of HSV-1. Of central interest in these recent investigations are the pathological roles played by human GI tract resident Gram-negative anaerobic bacteria and neurotropic viruses—two prominent divisions of GI tract microbiome-derived microbiota—which harbor considerable pathogenic potential. It is noteworthy that the first two well-studied microbiota—the GI tract abundant Gram-negative bacteria Bacteroides fragilis and the neurotropic herpes simplex virus-1 (HSV-1) both share a final common pathway of NF-κB (p50/p65) activation and microRNA-146a induction with ensuing pathogenic stimulation of innate-immune and neuroinflammatory pathways. These appear to strongly contribute to the inflammation-mediated amyloidogenic neuropathology of AD. The work in this paper: (i) expands recent research that has extended our understanding of the nature of the translocation of microbiome-derived neurotoxins-across biophysiological barriers; (ii) has assessed the induction of the pro-inflammatory pathogenic microRNA-146a by these two prominent classes of human GI-tract microbiota (B. fragilis and HSV-1); and (iii) advances the role of molecular neurobiology and mechanistic contribution of polymicrobial infections to AD-type neuropathological change.

Intestinal Microbiota Elicits IL‐17A Production in Neutrophil by Regulating RORγt Signaling and Accelerated the Pace of Inflammageing in Cerebral Small Vessel Disease

The gut-brain vascular axis in neuroinflammation

Gut Microbiota Mediates Neuroinflammation in Alzheimer’s Disease: Unraveling Key Factors and Mechanistic Insights

Lymphatic system and gut microbiota affect immunopathology of neuroinflammatory diseases, including multiple sclerosis, neuromyelitis optica and Alzheimer's disease

Abstract 2142: IL-17 Signaling In Intestinal Epithelial Cells Regulates Microbiota, Metabolism And Neuroinflammation In Atherosclerosis.

Effect of Intestinal Microbiota Transplantation on Cerebral Ischemia Reperfusion Injury in Aged Mice Via Inhibition of IL‐17

Gut microbiota from patients with arteriosclerotic CSVD induces higher IL-17A production in neutrophils via activating RORγt

Multi-omics analysis of gut-brain axis reveals novel microbial and neurotransmitter signatures in patients with arteriosclerotic cerebral small vessel disease

Alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease

Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis

The Role of the Gut Microbiome and Its Metabolites in Cerebrovascular Diseases

IL-17A-mediated alterations in gut microbiota composition, particularly changes in Prevotella abundance, impact Treg function in CNS Autoimmunity

Gut microbiota of old mice worsens neurological outcome after brain ischemia via increased valeric acid and IL-17 in the blood

Impact of gut-brain interaction in emerging neurological disorders

Neuroinflammation in the Brain and Role of Intestinal Microbiota: An Overview of the Players

Abstract 150: Cytokine Signaling In Intestinal Epithelial Cells As A Regulator Of Microbiota, Inflammation And Atherosclerosis

Age-Related Cognitive Decline Is Associated With Microbiota-Gut-Brain Axis Disorders And Neuroinflammation In Mice

The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology

Regulation of development of central nervous system and related diseases by gut microflora

Innate immune system signaling and CD11b+CD11c+CD103+ cell migration to the brain underlie changes in mouse behavior after microbial colonization.

P4‐099: GASTROINTESTINAL (GI) TRACT MICROBIOME‐MEDIATED UP‐REGULATION OF MICRORNA‐146A IN SPORADIC ALZHEIMER'S DISEASE BRAIN